Journal article · 2021
Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer
European Journal of Medicinal Chemistry, 228, 114013 · Published 26 November 2021 · DOI 10.1016/j.ejmech.2021.114013
In brief
“Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer” is a 2021 journal article by Quanyu Liu and 13 co-authors, published in European Journal of Medicinal Chemistry. OpenAlex counts 46 citations as of 22 November 2026, which puts it in the top 3% of works published in 2021 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 46
- Most cited in
- 2023 (12)
- Field-weighted impact
- 1.62
- References
- 38
- Authors
- 14
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Liu, Q., Tu, G., Hu, Y., Jiang, Q., Liu, J., Lin, S., Yu, Z., Li, G., Wu, X., Tang, Y., Huang, X., Xu, J., Liu, Y., & Wu, L. (2021). Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer. European Journal of Medicinal Chemistry, 228, 114013. https://doi.org/10.1016/j.ejmech.2021.114013
MLA 9
Liu, Quanyu, et al. “Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer.” European Journal of Medicinal Chemistry, vol. 228, 2021, p. 114013. https://doi.org/10.1016/j.ejmech.2021.114013.
Chicago
Liu, Quanyu, Guihui Tu, Yan Hu, Qingna Jiang, Jingwen Liu, Shanshan Lin, Zelei Yu, et al. 2021. “Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer.” European Journal of Medicinal Chemistry 228: 114013. https://doi.org/10.1016/j.ejmech.2021.114013.
Harvard
Liu, Q. et al. (2021) ‘Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer’, European Journal of Medicinal Chemistry, 228, p. 114013. doi:10.1016/j.ejmech.2021.114013.
IEEE
Q. Liu et al., “Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer,” European Journal of Medicinal Chemistry, vol. 228, p. 114013, 2021, doi: 10.1016/j.ejmech.2021.114013.
BibTeX
@article{liu2021discovery,
title = {{Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer}},
author = {Liu, Quanyu and Tu, Guihui and Hu, Yan and Jiang, Qingna and Liu, Jingwen and Lin, Shanshan and Yu, Zelei and Li, Ge and Wu, Xinhua and Tang, Yuanling and Huang, Xiuwang and Xu, Jianhua and Liu, Yang and Wu, Lixian},
journal = {European Journal of Medicinal Chemistry},
year = {2021},
volume = {228},
pages = {114013},
doi = {10.1016/j.ejmech.2021.114013},
url = {https://doi.org/10.1016/j.ejmech.2021.114013}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 9 | |
| 2023 | 12 | |
| 2024 | 5 | |
| 2025 | 10 | |
| 2026 | 10 |
Its field-weighted citation impact is 1.62: it has been cited 1.62 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- HSP90
- PROTACs
- breast cancer
- tumor suppression
- small-molecule drug design
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Liu, Q., Tu, G., Hu, Y., Jiang, Q., Liu, J., Lin, S., Yu, Z., Li, G., Wu, X., Tang, Y., Huang, X., Xu, J., Liu, Y., & Wu, L. (2021). Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer. European Journal of Medicinal Chemistry, 228, 114013. https://doi.org/10.1016/j.ejmech.2021.114013
How many times has this paper been cited?
46 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Quanyu Liu, Guihui Tu, Yan Hu, Qingna Jiang, Jingwen Liu, Shanshan Lin, Zelei Yu, Ge Li, Xinhua Wu, Yuanling Tang, Xiuwang Huang, Jianhua Xu and 2 more.
What is the DOI of this paper?
10.1016/j.ejmech.2021.114013, permanently at https://doi.org/10.1016/j.ejmech.2021.114013. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.